S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.78%) $83.20
Gas
(-1.16%) $1.619
Gold
(-0.03%) $2 346.50
Silver
(-0.16%) $27.49
Platinum
(0.26%) $924.50
USD/EUR
(-0.10%) $0.934
USD/NOK
(-0.07%) $11.02
USD/GBP
(-0.16%) $0.799
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai Bio-Techne Corp [TECH]

Birža: NASDAQ Sektorius: Healthcare Pramonė: Biotechnology
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 6.71%

BUY
66.00%
return 7.08%
SELL
34.69%
return 13.98%
Atnaujinta26 bal. 2024 @ 23:00

2.23% $ 64.06

PARDAVIMAS 3289 min ago

@ $64.15

Išleistas: 26 bal. 2024 @ 20:48


Grąža: -0.14%


Ankstesnis signalas: bal. 25 - 22:50


Ankstesnis signalas: Pirkimas


Grąža: 2.40 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):
Profile picture for Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide...

Stats
Šios dienos apimtis 946 213
Vidutinė apimtis 1.09M
Rinkos kapitalizacija 10.07B
EPS $0 ( 2024-02-01 )
Kita pelno data ( $0.460 ) 2024-05-01
Last Dividend $0.0800 ( 2023-11-09 )
Next Dividend $0 ( N/A )
P/E 46.09
ATR14 $1.869 (2.91%)
Insider Trading
Date Person Action Amount type
2024-04-03 Bohnen Shane Sell 2 259 Restricted Stock Units
2024-04-03 Bohnen Shane Buy 2 259 Common Stock
2024-04-03 Bohnen Shane Sell 747 Common Stock
2024-03-07 Nusse Roeland Sell 10 400 Common Stock
2024-02-01 Geist William Sell 1 111 Common Stock
INSIDER POWER
3.67
Last 99 transactions
Buy: 1 979 464 | Sell: 2 067 622

Tūris Koreliacija

Ilgas: -0.73 (moderate negative)
Trumpas: 0.92 (very strong)
Signal:(44) Expect same movement, but be aware

Bio-Techne Corp Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
MMAC0.917
NETE0.912
LWAC0.887
SRAC0.86
AMRB0.854
BLI0.815
10 Labiausiai neigiamai susiję koreliacijos
SVAC-0.935
TLGT-0.901
RMRM-0.897
PAIC-0.887
FEYE-0.864
SVOK-0.851
TEAM-0.842
UBOH-0.834
TRIN-0.833
INZY-0.827

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bio-Techne Corp Koreliacija - Valiuta/Žaliavos

The country flag 0.29
( neutral )
The country flag 0.45
( neutral )
The country flag 0.00
( neutral )
The country flag 0.54
( weak )
The country flag 0.21
( neutral )
The country flag -0.45
( neutral )

Bio-Techne Corp Finansinės ataskaitos

Annual 2023
Pajamos: $1.14B
Bruto pelnas: $769.82M (67.72 %)
EPS: $1.810
FY 2023
Pajamos: $1.14B
Bruto pelnas: $769.82M (67.72 %)
EPS: $1.810
FY 2022
Pajamos: $1.11B
Bruto pelnas: $756.50M (68.42 %)
EPS: $1.730
FY 2021
Pajamos: $931.03M
Bruto pelnas: $632.85M (67.97 %)
EPS: $0.867

Financial Reports:

No articles found.

Bio-Techne Corp Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0.0800
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Bio-Techne Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.04 - Stable (20.74%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0625 2008-10-30
Last Dividend $0.0800 2023-11-09
Next Dividend $0 N/A
Payout Date 2023-11-24
Next Payout Date N/A
# dividends 61 --
Total Paid Out $4.63 --
Avg. Dividend % Per Year 0.25% --
Score 4.89 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.04
Div. Directional Score 8.94 --
Next Divdend (Est)
(2024-07-01)
$0.0812 Estimate 39.51 %
Dividend Stability
0.79 Good
Dividend Score
4.89
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2008 $0.0625 0.37%
2009 $0.253 1.57%
2010 $0.263 1.53%
2011 $0.273 1.64%
2012 $0.285 1.66%
2013 $0.303 1.75%
2014 $0.313 1.33%
2015 $0.320 1.40%
2016 $0.320 1.45%
2017 $0.320 1.25%
2018 $0.320 0.97%
2019 $0.320 0.90%
2020 $0.320 0.58%
2021 $0.320 0.41%
2022 $0.320 0.26%
2023 $0.320 0.39%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1961.5006.089.13[0 - 0.5]
returnOnAssetsTTM0.08211.2007.268.72[0 - 0.3]
returnOnEquityTTM0.1151.5009.8410.00[0.1 - 1]
payoutRatioTTM0.225-1.0007.75-7.75[0 - 1]
currentRatioTTM4.370.80010.008.00[1 - 3]
quickRatioTTM2.540.80010.008.00[0.8 - 2.5]
cashRatioTTM0.9621.5005.778.65[0.2 - 2]
debtRatioTTM0.203-1.5006.61-9.91[0 - 0.6]
interestCoverageTTM20.761.0003.423.42[3 - 30]
operatingCashFlowPerShareTTM1.7552.009.4210.00[0 - 30]
freeCashFlowPerShareTTM1.4312.009.2810.00[0 - 20]
debtEquityRatioTTM0.283-1.5008.87-10.00[0 - 2.5]
grossProfitMarginTTM0.6711.0002.152.15[0.2 - 0.8]
operatingProfitMarginTTM0.2351.0007.317.31[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4971.0008.358.35[0.2 - 2]
assetTurnoverTTM0.4190.800-0.538-0.430[0.5 - 2]
Total Score11.84

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM45.021.0005.550[1 - 100]
returnOnEquityTTM0.1152.509.9010.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.4312.009.5210.00[0 - 30]
dividendYielPercentageTTM0.5001.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.7552.009.4210.00[0 - 30]
payoutRatioTTM0.2251.5007.75-7.75[0 - 1]
pegRatioTTM0.3351.500-1.1000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2411.0006.460[0.1 - 0.5]
Total Score6.04

Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.